Anti-Müllerian hormone, commonly known as AMH, has become one of the most discussed fertility tests for women over 35. A simple blood draw at any point during the menstrual cycle, an AMH test is often presented as a window into your “egg reserve.” But like most things in reproductive medicine, the picture it paints is more nuanced than a single number might suggest.
For women navigating fertility questions after 35, understanding what AMH actually measures — and, equally importantly, what it doesn’t — can help put test results into a more useful context. This is an important part of understanding fertility testing after 35.
What Is AMH and Why Is It Measured?
AMH is a hormone produced by small, developing follicles in the ovaries — specifically, the granulosa cells surrounding immature eggs. Because AMH production correlates with the number of these small follicles, blood levels of AMH are used as a proxy for ovarian reserve: essentially, the pool of remaining eggs.
One advantage of AMH testing is that it can be measured at any point in the menstrual cycle, unlike some other hormonal markers. Research from the National Institutes of Health has explored AMH’s role in predicting ovarian response to stimulation in assisted reproduction, where its utility appears most established.
How AMH Levels Change With Age
AMH levels naturally decline with age, reflecting the ongoing reduction in the number of follicles in the ovaries. Women in their late thirties typically have lower AMH levels than women in their mid-twenties, and levels continue to fall as menopause approaches. Reference ranges vary between laboratories, which is one reason the same AMH value might be interpreted differently depending on where the test was performed. AMH results should always be interpreted by a clinician using age-appropriate reference ranges rather than assessed against generic online reference ranges.
What AMH Can Tell You
Ovarian Reserve Context
AMH provides useful information about ovarian reserve — the quantity of eggs remaining. A higher AMH is generally associated with a larger follicular pool, while a lower AMH suggests a smaller one. In the context of IVF or other ovarian stimulation protocols, AMH levels help clinicians predict how many eggs are likely to be retrieved — a piece of information relevant to planning treatment.
Timing of Conversations With Your Doctor
For women over 35 thinking about conceiving, AMH testing can support conversations about timing. If AMH levels suggest a more limited ovarian reserve, some clinicians may recommend not waiting too long before pursuing fertility support, given that reserve tends to decline further with time.
What AMH Cannot Tell You
Egg Quality
AMH reflects egg quantity, not quality. Egg quality — which includes chromosomal integrity and the capacity to develop into a healthy embryo — is one of the most important factors in both natural conception and assisted reproduction. A woman with a low AMH may still have good egg quality, and vice versa.
Whether You Can Get Pregnant Naturally
AMH is not designed to predict whether natural conception is possible. Studies show that many women with low AMH conceive naturally, and AMH levels are not a reliable predictor of natural conception. AMH was developed and validated primarily in the context of predicting ovarian response to IVF stimulation, not in predicting natural pregnancy.
Your Exact Biological Clock
While AMH tends to decline before menopause, it is not a precise predictor of when menopause will occur for any individual. Current evidence does not support using AMH alone as a reliable predictor of an individual woman’s reproductive timeline.
Factors That Can Affect AMH Levels
AMH levels can be influenced by several factors beyond age. Vitamin D status has been associated with AMH levels in some research. Hormonal contraceptive use may temporarily suppress AMH levels. Conditions including PCOS are associated with higher AMH levels, while premature ovarian insufficiency is associated with significantly lower levels. Understanding what ovarian reserve means after 35 in the context of your complete health history is key to getting the most useful interpretation.
Frequently Asked Questions
Is a low AMH a reason to panic?
A lower-than-expected AMH result is understandably concerning, but it is not a definitive statement about your fertility. Many women with low AMH conceive naturally or with support. The most useful next step is to discuss your result with a reproductive endocrinologist who can interpret it in the context of your full health picture.
Can AMH levels be improved?
There is currently no well-established intervention proven to meaningfully increase AMH levels. Some supplements are studied in the context of IVF protocols, but their use should only be considered under the guidance of a fertility specialist.
Should I get an AMH test if I’m not ready to try to conceive yet?
AMH testing for “fertility awareness” outside of active family planning is a topic of debate among specialists. If you’re considering AMH testing for this purpose, discussing its potential benefits and limitations with your gynecologist beforehand is recommended.
How is AMH different from FSH?
Both AMH and FSH are used to assess ovarian reserve but measure different things. AMH is produced by follicles and declines as reserve diminishes; FSH is produced by the pituitary gland and tends to rise as reserve decreases. Both provide useful information and are often interpreted together.
Key Takeaways
- AMH measures ovarian reserve (egg quantity), not egg quality — and egg quality is a separate, equally important factor in fertility.
- AMH levels decline naturally with age, and interpretation should always be done by a clinician using age-appropriate reference ranges.
- A low AMH does not mean natural conception is impossible — AMH was validated primarily in the context of predicting IVF response, not natural pregnancy.
- Factors including vitamin D status, hormonal contraceptive use, and certain health conditions can influence AMH levels.
- AMH is most useful when interpreted as part of a comprehensive fertility evaluation including antral follicle count, FSH, and clinical history.
Medical Disclaimer
This content is for informational purposes only and does not constitute medical advice. Individual health situations vary significantly. Always consult a qualified healthcare provider before making decisions related to your health, fertility, or pregnancy.
About the Author
Emily Carter is a women’s health writer focused on fertility, pregnancy after 35, and sleep changes in midlife. She writes research-informed, non-alarmist content to help women navigate reproductive and hormonal transitions with clarity and confidence.